| TFAP2C | HeLa S3 (cervical adenocarcinoma) | None | Permissive
      
      Robust | Homo sapiens | wgEncodeEH000686 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive
      
      Robust | Homo sapiens | GSE105081
              
            
          
            
            ... | MA0814.2
        
      
        
        ... | 
  
    
    | TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive | Homo sapiens | GSE105081
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | WA09 (embryonic stem cells) | BMP4 for 3 day | Permissive
      
      Robust | Homo sapiens | GSE105081
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber:p16+ p37; Treatment: Naive(5iLAF) conditions; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p33; Treatment: 5 days in 5iLAF; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p28; CellType: Prime UCLA1 hESSCs; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: No Induc; | Permissive | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | UCLA1 hESCs | PasNumber: p52; Genotype: TFAP2C -/-; Treatment: transduced construct that allows doxycycline inducible expression of TFAP2C; | Permissive
      
      Robust | Homo sapiens | GSE101074
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MCF7 (Invasive ductal breast carcinoma) | Treatment: with Estrogen; | Permissive
      
      Robust | Homo sapiens | GSE117492
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MCF7 (Invasive ductal breast carcinoma) | Treatment: with Estrogen +1,6-Hexanediol; | Permissive
      
      Robust | Homo sapiens | GSE117492
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | A375 (malignant melanoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE41234 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | ZHBTc4-TS (trophoblast stem cells) |  | Permissive
      
      Robust | Mus musculus | GSE51511
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | mammary tumor |  | Permissive
      
      Robust | Mus musculus | GSE61394
              
            
          
            
            ... | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | BT-474 (breast invasive ductal carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE36351 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE36351 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MDA-MB-453 (breast adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE36351 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | SK-BR-3 (breast adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE36351 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MCF7 (Invasive ductal breast carcinoma) | E2 | Permissive
      
      Robust | Homo sapiens | GSE23852 | MA0524.2
        
      
        
        ... | 
  
    
    | TFAP2C | MCF7 (Invasive ductal breast carcinoma) | ETOH | Permissive
      
      Robust | Homo sapiens | GSE23852 | MA0524.2
        
      
        
        ... |